Vinge has advised Hansa Biopharma AB (publ).Hansa Biopharma AB (publ) has completed a directed share issue, raising approximately SEK 671.5 million before transaction costs. The transaction…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
